SNAP-8

$107.00

SNAP-8 (acetyl octapeptide-3) is a SNAP-25 C-terminal analog studied for topical SNARE-complex competition and expression-line cosmetic research. See mechanism and specifications.

SKU: N/A Category:

Description

SNAP-8 – Acetyl Octapeptide-3 Topical Research Peptide

SNAP-8 (acetyl octapeptide-3, also called acetyl glutamyl heptapeptide-1) is a synthetic 8-amino-acid peptide designed to mimic the N-terminus of SNAP-25, a protein component of the SNARE complex that mediates neurotransmitter release at the neuromuscular junction. It was developed specifically as a topical cosmetic research peptide – an extended analog of Argireline (acetyl hexapeptide-3), with two additional residues intended to improve SNARE-complex binding affinity. In research, SNAP-8 is the reference “SNARE-competitive” cosmetic research peptide and is studied almost exclusively in topical formulations targeting expression-line endpoints.


Why the SNAP-25 Mimetic Structure Matters

Muscle contraction requires neurotransmitter release across the neuromuscular junction. That release depends on the SNARE complex – a three-protein assembly (SNAP-25, syntaxin, VAMP) that docks acetylcholine-containing vesicles to the presynaptic membrane. SNAP-8 is engineered to compete with native SNAP-25 for assembly into the complex. When it binds, the complex is incomplete and vesicle docking is impaired. That mechanism is the same axis botulinum toxin targets – but by different means (toxin cleaves SNAP-25; SNAP-8 competes with it). The research distinction is why SNAP-8 shows up in “topical alternative to neuromuscular-blocker” cosmetic research.

Pathway What it does in plain terms
SNARE complex Competitive inhibition – SNAP-8 mimics SNAP-25 and disrupts complex assembly
Acetylcholine release Reduced at the neuromuscular junction in published in vitro work
Expression-line endpoints Reduced mimetic-muscle contraction in topical cosmetic research
Route of application Topical – penetration limited by peptide size and formulation vehicle

SNAP-8 vs Argireline

The two compounds are compared constantly in cosmetic peptide research. SNAP-8 is an extension of the Argireline structure.

Compound Structural difference
SNAP-8 8 amino acids – extended SNAP-25 N-terminus analog
Argireline (Acetyl Hexapeptide-3) 6 amino acids – shorter SNAP-25 N-terminus analog (the parent compound)

Research Applications

SNAP-8 is used in studies examining:

  • SNARE-complex competitive inhibition endpoints
  • Topical expression-line cosmetic formulation research
  • Acetylcholine-release in vitro research at the neuromuscular junction
  • Comparative cosmetic peptide research (SNAP-8 vs Argireline)
  • Non-injectable alternative mechanism research vs neuromuscular-blocking toxins
  • Peptide penetration and formulation-vehicle research

Specifications

Format Lyophilized powder
Purity ≥99%
Aliases SNAP-8, Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-1
Available sizes 10mg
Storage 2-8°C unopened; stable 12+ months
Use Research purposes only – not for human use

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for SNAP-8 are documented in the published peer-reviewed literature and standard peptide-chemistry references.


Reference Literature

Published clinical and preclinical SNAP-8 literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.


Common Questions About SNAP-8 Research

What is SNAP-8 used for in research?

It is studied as the reference SNARE-complex competitive research peptide. Published work covers topical expression-line cosmetic formulation endpoints, acetylcholine-release in vitro research, and comparative cosmetic peptide research against Argireline.

What is the difference between SNAP-8 and Argireline?

SNAP-8 is an 8-amino-acid extension of Argireline (acetyl hexapeptide-3, 6 amino acids). Both are SNAP-25 N-terminus mimetics that competitively disrupt SNARE-complex assembly. SNAP-8 was designed with two additional residues intended to improve SNARE-complex binding affinity. In cosmetic research literature, SNAP-8 is often marketed as “second-generation Argireline.”

Is SNAP-8 the same mechanism as botulinum toxin?

Both target the SNARE complex, but through different mechanisms. Botulinum toxin is a protease that enzymatically cleaves SNAP-25. SNAP-8 is a small peptide that competes with SNAP-25 for assembly into the SNARE complex. The toxin destroys the protein; the peptide blocks its assembly. Research framing treats them as axis-related but mechanistically distinct.

Is SNAP-8 FDA approved?

No. SNAP-8 is not an FDA-approved drug product. It is an ingredient used in cosmetic research formulations. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is SNAP-8 stored?

Unopened vials are stored at 2-8°C and stay stable for 12+ months. Once reconstituted or incorporated into a topical vehicle, store at 2-8°C and use within 28-30 days.


Purity Guarantee

Every batch is ≥99% purity. Send us a COA from any independent test and we’ll issue store credit regardless of what it shows.

Additional information

Milligrams Per Vial

10 mg

Reviews

There are no reviews yet.

Be the first to review “SNAP-8”

Your email address will not be published. Required fields are marked *